Case Report: BRCA1 and BRCA2 loss in a young man with primary cutaneous extraskeletal osteosarcoma

Bibliographic Details
Title: Case Report: BRCA1 and BRCA2 loss in a young man with primary cutaneous extraskeletal osteosarcoma
Authors: Wen-Feng Luo, Yu-Hang Hou, Yu-Teng Huang, Jun-Dong Lai, Hui-Shan Jiang, Wei-Liang Wang
Source: Frontiers in Oncology, Vol 15 (2025)
Publisher Information: Frontiers Media S.A., 2025.
Publication Year: 2025
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: osteosarcoma, primary cutaneous extraskeletal osteosarcoma, soft tissue tumor, BRCA1, BRCA2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: BackgroundExtraskeletal osteosarcoma is an uncommon and high-grade soft tissue malignancy. The incidence is even lower when the skin is the primary site. To the best of our knowledge, the primary cutaneous osteosarcoma has fewer than 30 reported cases worldwide, which with decreased copy number ofBRCA1 and BRCA2 has never been reported before.Case presentationA 28-year-old man was hospitalized for a skin mass on the left shoulder. The histological examination showed a large number of tumor giant cells and fibroblasts, and nuclear division was easy to see. Immunohistochemistry showed positive for CK, EMA, S100, CD34, CK7, Bcl-2, ACTin, and NSE, and negative for Vim, SATB2, CD99, SMA (focal), and Ki67 was about 40%. Shoulder joint CT and PET-CT showed that no metastasis presented. Germline testing showed decreased copy number ofBRCA1 and BRCA2. The diagnosis was cutaneous extraskeletal osteosarcomas of the left shoulder. The patient underwent an enlarged resection, followed by local radiotherapy four cycles. No recurrence or metastasis occurred on a 1-year of follow-up.ConclusionsPrimary cutaneous extraskeletal osteosarcoma (PC-EOS) is rare, and preoperative differential diagnosis is difficult. This is the first report of PC-EOS with decreased copy number of BRCA1 and BRCA2. The presented case highlights the importance of accurate histopathological examination and comprehensive analysis. We considered that BRCA1 and BRCA2 genes may are associated with a worse outcome and local recurrence in PC-EOS. But, it may not have been fully recognized.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2025.1504366/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2025.1504366
Access URL: https://doaj.org/article/5df7cab473224d47bc91d144a1de3e44
Accession Number: edsdoj.5df7cab473224d47bc91d144a1de3e44
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2025.1504366
Published in:Frontiers in Oncology
Language:English